News

Robotic surgery: a French first in oesophageal cancer

Following several pioneering procedures carried out in 2025 on the colon, pharynx and liver, the teams from the Department of Anaesthesia, Surgery and Interventional Medicine (DACI) at Gustave Roussy are continuing to drive innovation in robotic surgery. Using the da Vinci Single Port system, they successfully removed a patient’s diseased oesophagus without opening the chest, accessing it via a subcostal approach—an unprecedented achievement in France.

Published on

Salle d'opération

Following several pioneering procedures carried out in 2025 on the colon, pharynx and liver, the teams from the Department of Anaesthesia, Surgery and Interventional Medicine (DACI) at Gustave Roussy are continuing to drive innovation in robotic surgery. Using the da Vinci Single Port system, they successfully removed a patient’s diseased oesophagus without opening the chest, accessing it via a subcostal approach—an unprecedented achievement in France.

Salle d'opération

Gustave Roussy was among the first centres in France to be equipped with the da Vinci Single Port surgical system in early 2025. This technology makes it possible to perform complex procedures through a single incision of just a few centimetres, or even via natural orifices where feasible.

Supported by this technology, Dr Léonor Benhaim and her team performed a transdiaphragmatic oesophagectomy in April on a patient with oesophageal cancer. The procedure aimed to remove the diseased organ and reconstruct the digestive tract using a gastric pull-up.

Typically, access to the thoracic oesophagus requires several incisions between the ribs, an invasive approach that can be painful and is associated with a risk of postoperative pulmonary complications. In this case, thanks to the da Vinci Single Port system, the operation was carried out through a single incision of just a few centimetres at the level of the diaphragm, the muscle beneath the lungs and rib cage that separates the chest from the abdomen.

This significantly less invasive robotic approach helped reduce surgery-related complications. “Postoperative recovery was straightforward, with very little pain associated with this new approach,” notes Dr Léonor Benhaim. “This French first highlights the potential of robotic surgery to reduce postoperative complications and to offer patients increasingly less invasive treatments,” she concludes.

Last news

  • Two photon-counting CT scanners now equip Gustave Roussy's imaging department

    Since September 2026, Gustave Roussy's Department of Medical Imaging has been equipped with a second photon-counting CT scanner, delivering higher image resolution while reducing the doses of X-rays and contrast agent administered to patients. This technology recently enabled the Institute to perform an iodine-free pulmonary CT angiogram, a world first.

    Photographie du scanner à comptage photonique
  • Prevention and screening: getting ahead of lung cancer

    To mark Thoracic Cancer Awareness Month and Tobacco-Free Month, two campaigns focusing on lung cancer, Gustave Roussy highlights its initiatives to advance prevention and screening among people at increased risk. Since its creation in 2021, the Institute’s Interception Lung programme has welcomed more than 900 participants, supporting them to stop smoking and offering personalised screening for the disease.

    Photographie : patient effectuant un scanner thoracique et équipes soignantes
  • Gustave Roussy Meets His Audience

    As part of its awareness-raising and fundraising efforts, Gustave Roussy is currently conducting a door-to-door outreach campaign in several towns in Val-de-Marne (Fresnes, Vitry-sur-Seine, Nogent-sur-Marne, Bry-sur-Marne, Le Kremlin-Bicêtre) from Monday through Saturday, 1:30 p.m. to 8:00 p.m.

    Deux personnes en charge de la collecte porte-à-porte
  • Mens November: Take care of your jewelry its precious!

    November is the month dedicated to raising awareness and promoting prevention of male cancers, which include prostate, testicular, and penile cancers. The goal is to raise public awareness of these diseases—which account for approximately 63,000 new cases in France each year—and to encourage men to perform testicular self-exams, a simple step that can help detect a lump, the nature of which must then be determined through further medical examinations. Gustave Roussy has extensive expertise in the treatment of male cancers, particularly through its Genitourinary Oncology Committee, which is deeply involved in research on these diseases. 

    Visuel fixe campagne novembre masculin